Daniel Rabinowitz - 27 Feb 2024 Form 4 Insider Report for Natera, Inc. (NTRA)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
29 Feb 2024, 21:15:17 UTC
Prior SEC filing
30 Jan 2024
Next SEC filing
01 Mar 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Tami Chen, Attorney-in-Fact

Key filing fact

Daniel Rabinowitz filed Form 4 for Natera, Inc. (NTRA) on 29 Feb 2024.

Key facts

  • This page summarizes Daniel Rabinowitz's Form 4 filing for Natera, Inc. (NTRA).
  • 11 reported transactions and 3 derivative rows are listed below.
  • Accepted by SEC: 29 Feb 2024, 21:15.

Change

  • Previous filing in this sequence was filed on 30 Jan 2024.
  • Current net transaction value: -$3,928,780.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NTRA transaction

Common Stock

Options Exercise

Transaction value
$286,275
Shares
+27,500
Change %
+13%
Price
$10.41
Shares after
231,718
Date
27 Feb 2024
Ownership
Direct
NTRA transaction

Common Stock

Options Exercise

Transaction value
$72,527
Shares
+7,807
Change %
+3.4%
Price
$9.29
Shares after
239,525
Date
27 Feb 2024
Ownership
Direct
NTRA transaction

Common Stock

Sale

Transaction value
$2,651,298
Shares
-35,307
Change %
-15%
Price
$75.09
Shares after
204,218
Date
27 Feb 2024
Ownership
Direct
Footnotes
F1, F2
NTRA transaction

Common Stock

Options Exercise

Transaction value
$190,687
Shares
+20,526
Change %
+10%
Price
$9.29
Shares after
224,744
Date
29 Feb 2024
Ownership
Direct
NTRA transaction

Common Stock

Sale

Transaction value
$8,510
Shares
-100
Change %
-0.04%
Price
$85.10
Shares after
224,644
Date
29 Feb 2024
Ownership
Direct
Footnotes
F1
NTRA transaction

Common Stock

Sale

Transaction value
$225,344
Shares
-2,600
Change %
-1.2%
Price
$86.67
Shares after
222,044
Date
29 Feb 2024
Ownership
Direct
Footnotes
F1, F3
NTRA transaction

Common Stock

Sale

Transaction value
$298,765
Shares
-3,400
Change %
-1.5%
Price
$87.87
Shares after
218,644
Date
29 Feb 2024
Ownership
Direct
Footnotes
F1, F4
NTRA transaction

Common Stock

Sale

Transaction value
$1,294,351
Shares
-14,426
Change %
-6.6%
Price
$89.72
Shares after
204,218
Date
29 Feb 2024
Ownership
Direct
Footnotes
F1, F5

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NTRA transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value
$0
Shares
-27,500
Change %
-100%
Price
$0.000000*
Shares after
0
Date
27 Feb 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
27,500
Exercise price
$10.41
Footnotes
F6
NTRA transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value
$0
Shares
-7,807
Change %
-28%
Price
$0.000000
Shares after
20,526
Date
27 Feb 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
7,807
Exercise price
$9.29
Footnotes
F6
NTRA transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value
$0
Shares
-20,526
Change %
-100%
Price
$0.000000*
Shares after
0
Date
29 Feb 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
20,526
Exercise price
$9.29
Footnotes
F6
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 6 footnotes

Footnote F1

The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2022.

Footnote F2

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.00 to $75.49 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F3

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.43 to $87.00 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F4

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.80 to $88.00 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F5

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.53 to $89.78 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F6

The option shares are fully exercisable.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .